France has approved use of the Oxford/AstraZeneca coronavirus vaccine in individuals with existing illness aged between 65 and 74.
It means previous advice – that the jab needs to be for under-65s just – has been reversed.
In late January, President Emmanuel Macron declared the British-developed vaccine was “quasi-ineffective” in those of pensionable age.
However he stated last week that he would accept the inoculation, and now German Chancellor Angela Merkel is being advised not just to embrace the very same stance, but to have the Oxford jab herself.
Germany still doesn’t advise the jab for over-65s, although updated suggestions is anticipated quickly.
Live COVID updates from the UK and worldwide
Please use Chrome web browser for a more available video player UK: Vaccine data offers ‘self-confidence’ as deaths fall
France at first said that data from trials in older age was limited, echoing the stance taken in Germany.
Ever since, however, further research study has actually supplied more evidence of the vaccine’s efficacy.
In the UK – which authorized its use in all age just before the turn of the year – a single shot has actually been discovered to be more than 80% reliable at preventing hospitalisation amongst the over 80s.
As of Friday, France had utilized less than a quarter of the 1.1 m AstraZeneca dosages it had actually gotten, according to federal government information.
It has actually likewise been struggling with a shortage of vaccines from its other suppliers, Pfizer and Moderna.
Health Minister Olivier Veran informed BFMTV: “Any person aged 50 or over who is affected by co-morbidities can get the AstraZeneca vaccine, consisting of those between 65 and 74.”
He included that those 75 and over would continue to get the Pfizer and Moderna jabs only.
Mr Veran said that individuals who have actually had COVID-19 in current months will need only one dosage of those 2 vaccines.
Current infection functions as a partial protection versus the virus, meaning a 2nd dosage isn’t important, France’s High Authority for Health has actually argued.
Please use Chrome web browser for a more accessible video player ‘Fantastic unpredictability’ over foreign vacations
The sluggishness of the vaccine rollout in the EU has actually caused intense criticism from newspapers.
Filipp Piatov, head of opinion at German tabloid Bild, informed Sky News the pandemic had been “the very first test” after Brexit.
” Great Britain has actually passed and the European Union has failed,” he stated, adding: “I do not know where to start – a lot went wrong.”
Mr Piatov stated the scenario was “particularly bitter for Germans” due to the fact that the Pfizer/BioNTech jab was established there, and yet the UK and US purchased it months before the EU did.
“We simply do not understand how that could happen,” he said.
Mr Piatov and his paper think it would be a “very strong statement from Angela Merkel” were she to get an AstraZeneca jab.
It would prove the German leader believes in the vaccine and could encourage more Germans to do the very same, he said.
Recently, Germany’s health ministry said it had administered only 15% of the AstraZeneca shots it had readily available.
Health Minister Jens Spahn has stated the jab is “highly” advised, including: “This vaccine is safe and efficient, it protects.
“It protects oneself and others, like both other vaccines.”